Evidence map›Paper›PMID 35691374›Full record

ArticleExperimental eye research2022

The application of lentiviral vectors for the establishment of TGFβ2-induced ocular hypertension in C57BL/6J mice.

Michael Peng, Tyler J Margetts, Naga Pradeep Rayana, Chenna Kesavulu Sugali, Jiannong Dai, Weiming Mao

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. GSK3β Inhibitors Inhibit TGFβ Signaling in the Human Trabecular Meshwork.Investigative ophthalmology & visual science · 2024
    Article
  3. Article
  4. Article
  5. Viral Vector-Induced Ocular Hypertension in Mice.Methods in molecular biology (Clifton, N.J.) · 2023
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michael PengEugene & Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, USA.
Tyler J MargettsEugene & Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, USA.
Naga Pradeep RayanaEugene & Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, USA.
Chenna Kesavulu SugaliEugene & Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, USA.
Jiannong DaiEugene & Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, USA.
Weiming MaoEugene & Marilyn Glick Eye Institute, Department of Ophthalmology, Indiana University School of Medicine, USA; Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, USA; Department of Pharmacology and Toxicology, Indiana University School of Medicine, USA. Electronic address: weimmao@iu.edu.
Indiana University School of Medicine

Funding

Quality Assurance and Quality Control Project Management: Improving Submissions and Study Conduct in the Human Subjects Research Prior Approval ProcessUL1TR002529 · NCATS · INDIANA UNIVERSITY INDIANAPOLIS · PI MOE, SHARON M, WIEHE, SARAH ELIZABETH · 2018 to 2022
$27.2M
The role of Wnt signaling in treating glucocorticoid-induced glaucomaR01EY031700 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI MAO, WEIMING · 2021 to 2025
$2.5M
Cross-talk between TGF-beta and Wnt pathways in the trabecular meshworkR01EY026962 · NEI · UNIVERSITY OF NORTH TEXAS HLTH SCI CTR · PI MAO, WEIMING · 2017 to 2021
$1.9M
Short-Term Training in Ophthalmology Research for Medical StudentsT35EY031282 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI Ashay D Bhatwadekar, John Thompson Lind · 2020 to 2026
$354k
NCATS NIH HHS UL1 TR002529NEI NIH HHS R01 EY026962NEI NIH HHS R01 EY031700NEI NIH HHS T35 EY031282
6 · The paper itself

Abstract

Elevated levels of TGFβ2 in the aqueous humor is associated with the pathological changes in the trabecular meshwork (TM). These changes lead to ocular hypertension (OHT), the most important risk factor for the development and progression of primary open angle glaucoma (POAG), a leading cause of blindness worldwide. Therefore, TGFβ2 is frequently used to develop OHT models including in perfusion cultured eyes and in mouse eyes. Adenovirus-mediated overexpression of human mutant TGFβ2 has demonstrated great success in increasing intraocular pressure (IOP) in mouse eyes. However, adenoviruses have limited capacity for a foreign gene, induce transient expression, and may cause ocular inflammation. Here, we explored the potential of using lentiviral vectors carrying the mutant human TGFβ2

Indexed as

Cytomegalovirus InfectionsGlaucoma, Open-AngleOcular HypertensionAdenoviridaeAnimalsFemaleIntraocular PressureMaleMiceMice, Inbred C57BLTrabecular MeshworkTransforming Growth Factor beta2Transforming Growth Factor beta2Intraocular pressureLentivirusMouse modelOcular hypertensionTGFβ2Trabecular meshwork

Identifiers

PMID35691374
PMCPMC10953626
OpenAlexW4282929353

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.